US Stock MarketDetailed Quotes

RYTM Rhythm Pharmaceuticals

Watchlist
  • 38.500
  • -0.420-1.08%
Close May 9 16:00 ET
  • 39.260
  • +0.760+1.97%
Post 16:57 ET
2.35BMarket Cap-8315P/E (TTM)

About Rhythm Pharmaceuticals Company

Rhythm Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with rare diseases. The firm offers IMCIVREE (setmelanotide), a precision medicine designed to treat hyperphagia and severe obesity caused by rare melanocortin-4 receptor (MC4R) diseases. It is also involved in the clinical development program for setmelanotide in other rare MC4R pathway diseases, as well as a preclinical suite of investigational candidates for the treatment of congenital hyperinsulinism. The company was founded by Bart Henderson in November 2008 and is headquartered in Boston, MA.

Company Profile

SymbolRYTM
Company NameRhythm Pharmaceuticals
Listing DateOct 5, 2017
Issue Price17.00
Founded2008
CEODr. David P. Meeker,M.D.
MarketNASDAQ
Employees226
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address222 Berkeley Street,12th floor
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02116-3748
Phone1-857-264-4280
Websitehttp://www.rhythmtx.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. David P. Meeker,M.D.
  • Chairman of the Board, President and Chief Executive Officer
  • 7.23M
  • Hunter C. Smith
  • Chief Financial Officer and Treasurer
  • 2.31M
  • Pamela J. Cramer
  • Chief Human Resources Officer
  • --
  • Joseph Shulman
  • Chief Technical Officer
  • 1.74M
  • Christopher P. German
  • Director, Corporate Controller and Principal Accounting Officer
  • --
  • Jennifer Lee
  • Executive Vice President and Head of North America
  • 2.11M
  • Yann Mazabraud
  • Executive Vice President and Head of International
  • 1.74M
  • Lynn A. Tetrault, J.D.
  • Independent Director
  • 298.77K
  • Stuart A. Arbuckle
  • Independent Director
  • 301.27K
  • David W.J. McGirr, M.B.A.
  • Independent Director
  • 308.77K
  • Christophe R. Jean
  • Independent Director
  • 293.77K
  • Dr. Camille L. Bedrosian,M.D.
  • Independent Director
  • 296.27K
  • Jennifer L. Good
  • Independent Director
  • 283.77K
  • Edward T. Mathers
  • Lead Independent Director
  • 328.77K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg